A recent LinkedIn post from Gallant highlights an upcoming GallantU continuing education webinar focused on mesenchymal stromal cell therapy in animal health biotechnology. The session, scheduled for March 18 at 7:00 p.m. ET, is described as RACE-approved and offers one CE credit for participating veterinarians.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post indicates that Gallant’s Director of Veterinary Affairs, Rebecca Windsor, DVM, DACVIM, will address common questions from veterinarians and host a live Q&A segment. This emphasis on practitioner education may support Gallant’s positioning as a thought leader in veterinary regenerative medicine, potentially strengthening adoption of its technologies and enhancing long-term commercial prospects in the animal health market.